Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene Colice

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
ERJ Open Research|October 13, 2016
Add-on LABA in a separate inhaler as asthma step-up therapy <i>versus</i> increased dose of ICS or ICS/LABA combination inhalerDavid B Price, Gene Colice, Elliot Israel, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.
The New England Journal of Medicine|May 12, 2021
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled AsthmaAndrew Menzies-Gow, Jonathan Corren, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology|April 18, 2013
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasoneGene Colice, Richard J Martin, Elliot Israel, et al.
NPJ Primary Care Respiratory Medicine|October 10, 2014
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort studyRichard J Martin, David Price, Nicolas Roche, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 studyMichael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2015
Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthmaNicolas Roche, Dirkje S Postma, Gene Colice, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2015
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood AsthmaWillem M C van Aalderen, Jonathan Grigg, Theresa W Guilbert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2017
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled CorticosteroidsTheresa W Guilbert, Gene Colice, Jonathan Grigg, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
ERJ Open Research|October 13, 2016
Add-on LABA in a separate inhaler as asthma step-up therapy <i>versus</i> increased dose of ICS or ICS/LABA combination inhalerDavid B Price, Gene Colice, Elliot Israel, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.
The New England Journal of Medicine|May 12, 2021
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled AsthmaAndrew Menzies-Gow, Jonathan Corren, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology|April 18, 2013
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasoneGene Colice, Richard J Martin, Elliot Israel, et al.
NPJ Primary Care Respiratory Medicine|October 10, 2014
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort studyRichard J Martin, David Price, Nicolas Roche, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 studyMichael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2015
Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthmaNicolas Roche, Dirkje S Postma, Gene Colice, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2015
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood AsthmaWillem M C van Aalderen, Jonathan Grigg, Theresa W Guilbert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2017
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled CorticosteroidsTheresa W Guilbert, Gene Colice, Jonathan Grigg, et al.
Pageof 7